Putrajaya paid a premium price for some of Sinovac’s Covid-19 vaccines amid pressing need due to Pharmaniaga’s delay in delivering vaccines between April and May this year, said the Public Accounts Committee (PAC).

This was one of the PAC's findings in their report, published today, on Covid-19 vaccine procurement and its usage for Malaysian citizens, under the Science, Technology, and Innovation Ministry, Health Ministry, and Finance Ministry.

“The PAC is satisfied that the procurement prices for the vaccines from various portfolios paid for by the government were reasonable.

“However, the PAC found that...